Chief Executive Officer of Sanofi*
Date of birth: October 14, 1967
First elected: September 2019
Last reappointment: May 2022
Term expires: General Meeting 2026
Business address: 46, avenue de la Grande Armée - 75017 Paris (France)
Director / Chairman of the Executive Committee / Member of the Strategy Committee
Education and business experience
Paul Hudson joined Sanofi as CEO on September 1, 2019.
Previously CEO of Novartis Pharmaceuticals (2016-2019), where he was a member of the Executive Committee, Paul has an expansive international career in healthcare that spans the U.S., Japan and Europe.
Prior to Novartis, he worked for AstraZeneca, where he held several increasingly senior positions and most recently carried out the roles of president, AstraZeneca United States and executive vice president, North America.
He began his career in sales and marketing roles at GlaxoSmithKline UK and Sanofi-Synthélabo U.K.
Paul holds a degree in economics from Manchester Metropolitan University in the U.K. and last year his alma mater awarded him an honorary Doctor of Business Administration for his achievements in industry. He also holds a diploma in marketing from the Chartered Institute of Marketing, also in the U.K.
“People are what drive me. I was drawn to healthcare so that I could positively impact people’s lives. As a leader, I firmly believe that making an impact starts within–how we do things, how we work with integrity, and how we empower and inspire each other to bring our best selves to work. Even on a tough day, I can be confident that our work has a positive impact on people–either by improving a patient’s life or by inspiring a colleague.” - Paul Hudson
Directorships and appointments outside the Sanofi Group
Directorships as of 12/31/2021
(*) Listed companies are indicated by an asterisk.